Molecular Cytogenetics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Consumables, Software and Services, Instruments, Kits and Reagents); Technology (Comparative Genomic Hybridization, Fluorescence In Situ Hybridization (FISH), Immunohistochemistry, Karyotyping, Others); Application (Oncology, Personalized Medicine, Genetic Disorders, Others); End User (Hospitals, Clinical and Research Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies)

Report Code: TIPBT00002214 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW

Molecular cytogenetics involves the combination of molecular biology and cytogenetics. It involves use of various reagents which helps to properly distinguish normal and cancer causing cells. Molecular cytogenetics is a useful tool for diagnosing and treatment of various malignancies such as brain tumors, and haematological malignancies.

MARKET SCOPE

The "Global Molecular Cytogenetics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Molecular Cytogenetics market with detailed market segmentation by products, technology, application, end user and geography. The report provides key statistics on the market status of the leading Molecular Cytogenetics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on product, the global molecular cytogenetics market is segmented into consumables, instruments, kits and reagents, software and services.
  • Based on technique, the global molecular cytogenetics market is segmented into hybridization-based approach, and amplicon-based approach.
  • Based on technology, the global molecular cytogenetics market is segmented into comparative genomic hybridization, fluorescence in situ hybridization (FISH), immunohistochemistry, karyotyping, others.
  • Based on application, the global molecular cytogenetics market is segmented into oncology, personalized medicine, genetic disorders, others.
  • On the basis of end user, the market is segmented into hospitals, clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies.

MARKET DYNAMICS

Drivers

  • Increasing incidence of genetic disorders and cancer
  • Rise in prevalence of chronic diseases
  • Increasing molecular cytogenetics in clinical pathological testing
  • Growing inclination towards targeted cancer treatment

Restraints

  • High cost of advanced instruments

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Molecular Cytogenetics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Molecular Cytogenetics market in these regions.

IMPACT OF COVID-19 ON MOLECULAR CYTOGENETICS MARKET

The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. cytogenetic approaches are used to identify genomic variations. Growth in utilization of genetic information in predictive models for disease traits is increasing the adoption of cytogenetic tools. However, delay in clinical trials is expected to negatively impacting the growth of the market.

MARKET PLAYERS

The report covers key developments in the molecular cytogenetics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Molecular Cytogenetics market are anticipated to lucrative growth opportunities in the future with the rising demand for Molecular Cytogenetics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Molecular Cytogenetics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Applied Spectral Imaging
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • PerkinElmer Inc.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Abbott Laboratories
  • NeoGenomics Laboratories, Inc.
  • Danaher Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

 

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Molecular Cytogenetics Market - By Product
 1.3.2 Molecular Cytogenetics Market - By Technology
 1.3.3 Molecular Cytogenetics Market - By Application
 1.3.4 Molecular Cytogenetics Market - By End User
 1.3.5 Molecular Cytogenetics Market - By Region
 1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MOLECULAR CYTOGENETICS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. MOLECULAR CYTOGENETICS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MOLECULAR CYTOGENETICS MARKET - GLOBAL MARKET ANALYSIS
 6.1. MOLECULAR CYTOGENETICS - GLOBAL MARKET OVERVIEW
 6.2. MOLECULAR CYTOGENETICS - GLOBAL MARKET AND FORECAST TO 2028
 6.3. MARKET POSITIONING
7. MOLECULAR CYTOGENETICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
 7.1. OVERVIEW
 7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
 7.3. CONSUMABLES
 7.3.1. Overview
 7.3.2. Consumables Market Forecast and Analysis
 7.4. SOFTWARE AND SERVICES
 7.4.1. Overview
 7.4.2. Software and Services Market Forecast and Analysis
 7.5. INSTRUMENTS
 7.5.1. Overview
 7.5.2. Instruments Market Forecast and Analysis
 7.6. KITS AND REAGENTS
 7.6.1. Overview
 7.6.2. Kits and Reagents Market Forecast and Analysis
8. MOLECULAR CYTOGENETICS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
 8.1. OVERVIEW
 8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
 8.3. COMPARATIVE GENOMIC HYBRIDIZATION
 8.3.1. Overview
 8.3.2. Comparative Genomic Hybridization Market Forecast and Analysis
 8.3.3. Array-based Comparative Genomic Hybridization Market
 8.3.3.1. Overview
 8.3.3.2. Array-based Comparative Genomic Hybridization Market Forecast and Analysis
 8.3.4. Standard Comparative Genomic Hybridization Market
 8.3.4.1. Overview
 8.3.4.2. Standard Comparative Genomic Hybridization Market Forecast and Analysis
 8.4. FLUORESCENCE IN SITU HYBRIDIZATION (FISH)
 8.4.1. Overview
 8.4.2. Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis
 8.5. IMMUNOHISTOCHEMISTRY
 8.5.1. Overview
 8.5.2. Immunohistochemistry Market Forecast and Analysis
 8.6. KARYOTYPING
 8.6.1. Overview
 8.6.2. Karyotyping Market Forecast and Analysis
 8.6.3. Spectral Karyotyping Market
 8.6.3.1. Overview
 8.6.3.2. Spectral Karyotyping Market Forecast and Analysis
 8.6.4. Virtual Karyotyping Market
 8.6.4.1. Overview
 8.6.4.2. Virtual Karyotyping Market Forecast and Analysis
 8.7. OTHERS
 8.7.1. Overview
 8.7.2. Others Market Forecast and Analysis
9. MOLECULAR CYTOGENETICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
 9.1. OVERVIEW
 9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
 9.3. ONCOLOGY
 9.3.1. Overview
 9.3.2. Oncology Market Forecast and Analysis
 9.4. PERSONALIZED MEDICINE
 9.4.1. Overview
 9.4.2. Personalized Medicine Market Forecast and Analysis
 9.5. GENETIC DISORDERS
 9.5.1. Overview
 9.5.2. Genetic Disorders Market Forecast and Analysis
 9.6. OTHERS
 9.6.1. Overview
 9.6.2. Others Market Forecast and Analysis
10. MOLECULAR CYTOGENETICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
 10.1. OVERVIEW
 10.2. END USER MARKET FORECASTS AND ANALYSIS
 10.3. HOSPITALS
 10.3.1. Overview
 10.3.2. Hospitals Market Forecast and Analysis
 10.4. CLINICAL AND RESEARCH LABORATORIES
 10.4.1. Overview
 10.4.2. Clinical and Research Laboratories Market Forecast and Analysis
 10.5. ACADEMIC RESEARCH INSTITUTES
 10.5.1. Overview
 10.5.2. Academic Research Institutes Market Forecast and Analysis
 10.6. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
 10.6.1. Overview
 10.6.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
11. MOLECULAR CYTOGENETICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
 11.1. NORTH AMERICA
 11.1.1 North America Molecular Cytogenetics Market Overview
 11.1.2 North America Molecular Cytogenetics Market Forecasts and Analysis
 11.1.3 North America Molecular Cytogenetics Market Forecasts and Analysis - By Product
 11.1.4 North America Molecular Cytogenetics Market Forecasts and Analysis - By Technology
 11.1.5 North America Molecular Cytogenetics Market Forecasts and Analysis - By Application
 11.1.6 North America Molecular Cytogenetics Market Forecasts and Analysis - By End User
 11.1.7 North America Molecular Cytogenetics Market Forecasts and Analysis - By Countries
 11.1.7.1 United States Molecular Cytogenetics Market
 11.1.7.1.1 United States Molecular Cytogenetics Market by Product
 11.1.7.1.2 United States Molecular Cytogenetics Market by Technology
 11.1.7.1.3 United States Molecular Cytogenetics Market by Application
 11.1.7.1.4 United States Molecular Cytogenetics Market by End User
 11.1.7.2 Canada Molecular Cytogenetics Market
 11.1.7.2.1 Canada Molecular Cytogenetics Market by Product
 11.1.7.2.2 Canada Molecular Cytogenetics Market by Technology
 11.1.7.2.3 Canada Molecular Cytogenetics Market by Application
 11.1.7.2.4 Canada Molecular Cytogenetics Market by End User
 11.1.7.3 Mexico Molecular Cytogenetics Market
 11.1.7.3.1 Mexico Molecular Cytogenetics Market by Product
 11.1.7.3.2 Mexico Molecular Cytogenetics Market by Technology
 11.1.7.3.3 Mexico Molecular Cytogenetics Market by Application
 11.1.7.3.4 Mexico Molecular Cytogenetics Market by End User
 11.2. EUROPE
 11.2.1 Europe Molecular Cytogenetics Market Overview
 11.2.2 Europe Molecular Cytogenetics Market Forecasts and Analysis
 11.2.3 Europe Molecular Cytogenetics Market Forecasts and Analysis - By Product
 11.2.4 Europe Molecular Cytogenetics Market Forecasts and Analysis - By Technology
 11.2.5 Europe Molecular Cytogenetics Market Forecasts and Analysis - By Application
 11.2.6 Europe Molecular Cytogenetics Market Forecasts and Analysis - By End User
 11.2.7 Europe Molecular Cytogenetics Market Forecasts and Analysis - By Countries
 11.2.7.1 Germany Molecular Cytogenetics Market
 11.2.7.1.1 Germany Molecular Cytogenetics Market by Product
 11.2.7.1.2 Germany Molecular Cytogenetics Market by Technology
 11.2.7.1.3 Germany Molecular Cytogenetics Market by Application
 11.2.7.1.4 Germany Molecular Cytogenetics Market by End User
 11.2.7.2 France Molecular Cytogenetics Market
 11.2.7.2.1 France Molecular Cytogenetics Market by Product
 11.2.7.2.2 France Molecular Cytogenetics Market by Technology
 11.2.7.2.3 France Molecular Cytogenetics Market by Application
 11.2.7.2.4 France Molecular Cytogenetics Market by End User
 11.2.7.3 Italy Molecular Cytogenetics Market
 11.2.7.3.1 Italy Molecular Cytogenetics Market by Product
 11.2.7.3.2 Italy Molecular Cytogenetics Market by Technology
 11.2.7.3.3 Italy Molecular Cytogenetics Market by Application
 11.2.7.3.4 Italy Molecular Cytogenetics Market by End User
 11.2.7.4 Spain Molecular Cytogenetics Market
 11.2.7.4.1 Spain Molecular Cytogenetics Market by Product
 11.2.7.4.2 Spain Molecular Cytogenetics Market by Technology
 11.2.7.4.3 Spain Molecular Cytogenetics Market by Application
 11.2.7.4.4 Spain Molecular Cytogenetics Market by End User
 11.2.7.5 United Kingdom Molecular Cytogenetics Market
 11.2.7.5.1 United Kingdom Molecular Cytogenetics Market by Product
 11.2.7.5.2 United Kingdom Molecular Cytogenetics Market by Technology
 11.2.7.5.3 United Kingdom Molecular Cytogenetics Market by Application
 11.2.7.5.4 United Kingdom Molecular Cytogenetics Market by End User
 11.2.7.6 Rest of Europe Molecular Cytogenetics Market
 11.2.7.6.1 Rest of Europe Molecular Cytogenetics Market by Product
 11.2.7.6.2 Rest of Europe Molecular Cytogenetics Market by Technology
 11.2.7.6.3 Rest of Europe Molecular Cytogenetics Market by Application
 11.2.7.6.4 Rest of Europe Molecular Cytogenetics Market by End User
 11.3. ASIA-PACIFIC
 11.3.1 Asia-Pacific Molecular Cytogenetics Market Overview
 11.3.2 Asia-Pacific Molecular Cytogenetics Market Forecasts and Analysis
 11.3.3 Asia-Pacific Molecular Cytogenetics Market Forecasts and Analysis - By Product
 11.3.4 Asia-Pacific Molecular Cytogenetics Market Forecasts and Analysis - By Technology
 11.3.5 Asia-Pacific Molecular Cytogenetics Market Forecasts and Analysis - By Application
 11.3.6 Asia-Pacific Molecular Cytogenetics Market Forecasts and Analysis - By End User
 11.3.7 Asia-Pacific Molecular Cytogenetics Market Forecasts and Analysis - By Countries
 11.3.7.1 Australia Molecular Cytogenetics Market
 11.3.7.1.1 Australia Molecular Cytogenetics Market by Product
 11.3.7.1.2 Australia Molecular Cytogenetics Market by Technology
 11.3.7.1.3 Australia Molecular Cytogenetics Market by Application
 11.3.7.1.4 Australia Molecular Cytogenetics Market by End User
 11.3.7.2 China Molecular Cytogenetics Market
 11.3.7.2.1 China Molecular Cytogenetics Market by Product
 11.3.7.2.2 China Molecular Cytogenetics Market by Technology
 11.3.7.2.3 China Molecular Cytogenetics Market by Application
 11.3.7.2.4 China Molecular Cytogenetics Market by End User
 11.3.7.3 India Molecular Cytogenetics Market
 11.3.7.3.1 India Molecular Cytogenetics Market by Product
 11.3.7.3.2 India Molecular Cytogenetics Market by Technology
 11.3.7.3.3 India Molecular Cytogenetics Market by Application
 11.3.7.3.4 India Molecular Cytogenetics Market by End User
 11.3.7.4 Japan Molecular Cytogenetics Market
 11.3.7.4.1 Japan Molecular Cytogenetics Market by Product
 11.3.7.4.2 Japan Molecular Cytogenetics Market by Technology
 11.3.7.4.3 Japan Molecular Cytogenetics Market by Application
 11.3.7.4.4 Japan Molecular Cytogenetics Market by End User
 11.3.7.5 South Korea Molecular Cytogenetics Market
 11.3.7.5.1 South Korea Molecular Cytogenetics Market by Product
 11.3.7.5.2 South Korea Molecular Cytogenetics Market by Technology
 11.3.7.5.3 South Korea Molecular Cytogenetics Market by Application
 11.3.7.5.4 South Korea Molecular Cytogenetics Market by End User
 11.3.7.6 Rest of Asia-Pacific Molecular Cytogenetics Market
 11.3.7.6.1 Rest of Asia-Pacific Molecular Cytogenetics Market by Product
 11.3.7.6.2 Rest of Asia-Pacific Molecular Cytogenetics Market by Technology
 11.3.7.6.3 Rest of Asia-Pacific Molecular Cytogenetics Market by Application
 11.3.7.6.4 Rest of Asia-Pacific Molecular Cytogenetics Market by End User
 11.4. MIDDLE EAST AND AFRICA
 11.4.1 Middle East and Africa Molecular Cytogenetics Market Overview
 11.4.2 Middle East and Africa Molecular Cytogenetics Market Forecasts and Analysis
 11.4.3 Middle East and Africa Molecular Cytogenetics Market Forecasts and Analysis - By Product
 11.4.4 Middle East and Africa Molecular Cytogenetics Market Forecasts and Analysis - By Technology
 11.4.5 Middle East and Africa Molecular Cytogenetics Market Forecasts and Analysis - By Application
 11.4.6 Middle East and Africa Molecular Cytogenetics Market Forecasts and Analysis - By End User
 11.4.7 Middle East and Africa Molecular Cytogenetics Market Forecasts and Analysis - By Countries
 11.4.7.1 South Africa Molecular Cytogenetics Market
 11.4.7.1.1 South Africa Molecular Cytogenetics Market by Product
 11.4.7.1.2 South Africa Molecular Cytogenetics Market by Technology
 11.4.7.1.3 South Africa Molecular Cytogenetics Market by Application
 11.4.7.1.4 South Africa Molecular Cytogenetics Market by End User
 11.4.7.2 Saudi Arabia Molecular Cytogenetics Market
 11.4.7.2.1 Saudi Arabia Molecular Cytogenetics Market by Product
 11.4.7.2.2 Saudi Arabia Molecular Cytogenetics Market by Technology
 11.4.7.2.3 Saudi Arabia Molecular Cytogenetics Market by Application
 11.4.7.2.4 Saudi Arabia Molecular Cytogenetics Market by End User
 11.4.7.3 U.A.E Molecular Cytogenetics Market
 11.4.7.3.1 U.A.E Molecular Cytogenetics Market by Product
 11.4.7.3.2 U.A.E Molecular Cytogenetics Market by Technology
 11.4.7.3.3 U.A.E Molecular Cytogenetics Market by Application
 11.4.7.3.4 U.A.E Molecular Cytogenetics Market by End User
 11.4.7.4 Rest of Middle East and Africa Molecular Cytogenetics Market
 11.4.7.4.1 Rest of Middle East and Africa Molecular Cytogenetics Market by Product
 11.4.7.4.2 Rest of Middle East and Africa Molecular Cytogenetics Market by Technology
 11.4.7.4.3 Rest of Middle East and Africa Molecular Cytogenetics Market by Application
 11.4.7.4.4 Rest of Middle East and Africa Molecular Cytogenetics Market by End User
 11.5. SOUTH AND CENTRAL AMERICA
 11.5.1 South and Central America Molecular Cytogenetics Market Overview
 11.5.2 South and Central America Molecular Cytogenetics Market Forecasts and Analysis
 11.5.3 South and Central America Molecular Cytogenetics Market Forecasts and Analysis - By Product
 11.5.4 South and Central America Molecular Cytogenetics Market Forecasts and Analysis - By Technology
 11.5.5 South and Central America Molecular Cytogenetics Market Forecasts and Analysis - By Application
 11.5.6 South and Central America Molecular Cytogenetics Market Forecasts and Analysis - By End User
 11.5.7 South and Central America Molecular Cytogenetics Market Forecasts and Analysis - By Countries
 11.5.7.1 Brazil Molecular Cytogenetics Market
 11.5.7.1.1 Brazil Molecular Cytogenetics Market by Product
 11.5.7.1.2 Brazil Molecular Cytogenetics Market by Technology
 11.5.7.1.3 Brazil Molecular Cytogenetics Market by Application
 11.5.7.1.4 Brazil Molecular Cytogenetics Market by End User
 11.5.7.2 Argentina Molecular Cytogenetics Market
 11.5.7.2.1 Argentina Molecular Cytogenetics Market by Product
 11.5.7.2.2 Argentina Molecular Cytogenetics Market by Technology
 11.5.7.2.3 Argentina Molecular Cytogenetics Market by Application
 11.5.7.2.4 Argentina Molecular Cytogenetics Market by End User
 11.5.7.3 Rest of South and Central America Molecular Cytogenetics Market
 11.5.7.3.1 Rest of South and Central America Molecular Cytogenetics Market by Product
 11.5.7.3.2 Rest of South and Central America Molecular Cytogenetics Market by Technology
 11.5.7.3.3 Rest of South and Central America Molecular Cytogenetics Market by Application
 11.5.7.3.4 Rest of South and Central America Molecular Cytogenetics Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MOLECULAR CYTOGENETICS MARKET
 12.1 North America
 12.2 Europe
 12.3 Asia-Pacific
 12.4 Middle East and Africa
 12.5 South and Central America
13. INDUSTRY LANDSCAPE
 13.1. MERGERS AND ACQUISITIONS
 13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 13.3. NEW PRODUCT LAUNCHES
 13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. MOLECULAR CYTOGENETICS MARKET, KEY COMPANY PROFILES
 14.1. APPLIED SPECTRAL IMAGING
 14.1.1. Key Facts
 14.1.2. Business Description
 14.1.3. Products and Services
 14.1.4. Financial Overview
 14.1.5. SWOT Analysis
 14.1.6. Key Developments
 14.2. THERMO FISHER SCIENTIFIC INC.
 14.2.1. Key Facts
 14.2.2. Business Description
 14.2.3. Products and Services
 14.2.4. Financial Overview
 14.2.5. SWOT Analysis
 14.2.6. Key Developments
 14.3. BIO-RAD LABORATORIES, INC.
 14.3.1. Key Facts
 14.3.2. Business Description
 14.3.3. Products and Services
 14.3.4. Financial Overview
 14.3.5. SWOT Analysis
 14.3.6. Key Developments
 14.4. ILLUMINA, INC.
 14.4.1. Key Facts
 14.4.2. Business Description
 14.4.3. Products and Services
 14.4.4. Financial Overview
 14.4.5. SWOT Analysis
 14.4.6. Key Developments
 14.5. PERKINELMER INC.
 14.5.1. Key Facts
 14.5.2. Business Description
 14.5.3. Products and Services
 14.5.4. Financial Overview
 14.5.5. SWOT Analysis
 14.5.6. Key Developments
 14.6. F. HOFFMANN-LA ROCHE LTD
 14.6.1. Key Facts
 14.6.2. Business Description
 14.6.3. Products and Services
 14.6.4. Financial Overview
 14.6.5. SWOT Analysis
 14.6.6. Key Developments
 14.7. AGILENT TECHNOLOGIES, INC.
 14.7.1. Key Facts
 14.7.2. Business Description
 14.7.3. Products and Services
 14.7.4. Financial Overview
 14.7.5. SWOT Analysis
 14.7.6. Key Developments
 14.8. ABBOTT LABORATORIES
 14.8.1. Key Facts
 14.8.2. Business Description
 14.8.3. Products and Services
 14.8.4. Financial Overview
 14.8.5. SWOT Analysis
 14.8.6. Key Developments
 14.9. NEOGENOMICS LABORATORIES, INC.
 14.9.1. Key Facts
 14.9.2. Business Description
 14.9.3. Products and Services
 14.9.4. Financial Overview
 14.9.5. SWOT Analysis
 14.9.6. Key Developments
 14.10. DANAHER CORPORATION
 14.10.1. Key Facts
 14.10.2. Business Description
 14.10.3. Products and Services
 14.10.4. Financial Overview
 14.10.5. SWOT Analysis
 14.10.6. Key Developments
15. APPENDIX
 15.1. ABOUT THE INSIGHT PARTNERS
 15.2. GLOSSARY OF TERMS

 

The List of Companies

1. Applied Spectral Imaging
2. Thermo Fisher Scientific Inc.
3. Bio-Rad Laboratories, Inc.
4. Illumina, Inc.
5. PerkinElmer Inc.
6. F. Hoffmann-La Roche Ltd
7. Agilent Technologies, Inc.
8. Abbott Laboratories
9. NeoGenomics Laboratories, Inc.
10. Danaher Corporation
11. Oxford Gene Technology
12. CytoTest
13. Cytognomix
14. Genial Genetics
15. Diagnostic Cytogenetics, Inc.

 

TIPBT00002214
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking